Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(25%)
Results Posted
50%(1 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
66.7%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

recruiting125%
terminated125%
completed250%

Recent Activity

1 active trials
Showing 4 of 4
completednot_applicable

Hydrus Microstent for Refractory Open-Angle Glaucoma

NCT03267134
terminatednot_applicable

Safety and Effectiveness of the Hydrus Microstent

NCT05198297
recruiting

Frontal Alpha Asymmetry and Pediatric Emergence Delirium

NCT05800639
completed

Dafilon® Suture Material in Patients Undergoing Ophthalmic Surgery

NCT05968443

Clinical Trials (4)

Showing 4 of 4 trials
NCT03267134Not Applicable

Hydrus Microstent for Refractory Open-Angle Glaucoma

Completed
NCT05198297Not Applicable

Safety and Effectiveness of the Hydrus Microstent

Terminated
NCT05800639

Frontal Alpha Asymmetry and Pediatric Emergence Delirium

Recruiting
NCT05968443

Dafilon® Suture Material in Patients Undergoing Ophthalmic Surgery

Completed

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4